Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.
Condition(s):Atrial FibrillationLast Updated:February 14, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Atrial FibrillationLast Updated:February 14, 2023Recruiting
Condition(s):ArrhythmiaLast Updated:July 19, 2022Recruiting
Condition(s):Atrial Fibrillation, PersistentLast Updated:July 11, 2023Not yet recruiting
Condition(s):Persistent Atrial FibrillationLast Updated:March 22, 2024Recruiting
Condition(s):Mild Cognitive Impairment; Persistent Atrial FibrillationLast Updated:May 26, 2023Recruiting
Condition(s):Atrial Fibrillation; HFpEF – Heart Failure With Preserved Ejection FractionLast Updated:December 11, 2023Recruiting
Condition(s):Cardiovascular DiseasesLast Updated:June 15, 2023Recruiting
Condition(s):Acute Ischemic Stroke; Atrial FibrillationLast Updated:December 28, 2023Not yet recruiting
Condition(s):Atrial FibrillationLast Updated:August 15, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.